Phenotype of Striatofugal Medium Spiny Neurons in Parkinsonian and Dyskinetic Nonhuman Primates: A Call for a Reappraisal of the Functional Organization of the Basal Ganglia

The classic view of anatomofunctional organization of the basal ganglia is that striatopallidal neurons of the "indirect" pathway express D2 dopamine receptors and corelease enkephalin with GABA, whereas striatopallidal neurons of the "direct" pathway bear D1 dopamine receptors a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of neuroscience 2006-08, Vol.26 (34), p.8653-8661
Hauptverfasser: Nadjar, Agnes, Brotchie, Jonathan M, Guigoni, Celine, Li, Qin, Zhou, Shao-Bo, Wang, Gui-Jie, Ravenscroft, Paula, Georges, Francois, Crossman, Alan R, Bezard, Erwan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 8661
container_issue 34
container_start_page 8653
container_title The Journal of neuroscience
container_volume 26
creator Nadjar, Agnes
Brotchie, Jonathan M
Guigoni, Celine
Li, Qin
Zhou, Shao-Bo
Wang, Gui-Jie
Ravenscroft, Paula
Georges, Francois
Crossman, Alan R
Bezard, Erwan
description The classic view of anatomofunctional organization of the basal ganglia is that striatopallidal neurons of the "indirect" pathway express D2 dopamine receptors and corelease enkephalin with GABA, whereas striatopallidal neurons of the "direct" pathway bear D1 dopamine receptors and corelease dynorphin and substance P with GABA. Although many studies have investigated the pathophysiology of the basal ganglia after dopamine denervation and subsequent chronic levodopa (L-dopa) treatment, none has ever considered the possibility of plastic changes leading to profound reorganization and/or biochemical phenotype modifications of medium spiny neurons. Therefore, we studied the phenotype of striatal neurons in four groups of nonhuman primates, including the following: normal, parkinsonian, parkinsonian chronically treated with L-dopa without exhibiting dyskinesia, and parkinsonian chronically treated with L-dopa exhibiting overt dyskinesia. To identify striatal cells projecting to external (indirect) or internal (direct) segments of the globus pallidus, the retrograde tracer cholera toxin subunit B (CTb) was injected stereotaxically into the terminal areas. Using immunohistochemistry techniques, brain sections were double labeled for CTb and dopamine receptors, opioid peptides, or the substance P receptor (NK1). We also used HPLC-RIA to assess opioid levels throughout structures of the basal ganglia. Our results suggest that medium spiny neurons retain their phenotype because no variations were observed in any experimental condition. Therefore, it appears unlikely that dyskinesia is related to a phenotype modification of the striatal neurons. However, this study supports the concept of axonal collateralization of striatofugal cells that project to both globus pallidus pars externa and globus pallidus pars interna. Striatofugal pathways are not as segregated in the primate as previously considered.
doi_str_mv 10.1523/JNEUROSCI.2582-06.2006
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6674386</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>19314832</sourcerecordid><originalsourceid>FETCH-LOGICAL-c475t-b5a546bfb0e6fc1af5f1fbfef01b07883dfad9ee61f958b1b9a94341323dc5853</originalsourceid><addsrcrecordid>eNpVUd1u0zAYtRCIlcIrTL6CqxQ7P07CBdJWtjE02mpl19aXxG4MiR1sh6q8E--Io5YBV5bPOd85n30QOqdkQbM4eftpdfVwv94ubxdxVsQRYYuYEPYEzQJbRnFK6FM0I3FOIpbm6Rl64dxXQkhOaP4cnVFWxkWRJTP0a9MKbfxhENhIvPVWgTdy3EGHP4tGjT3eDkof8EqM1miHlcYbsN-UdkYr0Bh0gz8cXACEVzVeGd2OfcA3VvXghXuHL_ASug5LYzHgewHDYEG54B_yfCvw9ahrr4wOyNruQKufMF3_0JcwaW9A7zoFL9EzCZ0Tr07nHD1cX31Zfozu1je3y4u7qE7zzEdVBlnKKlkRwWRNQWaSykoKSWhF8qJIGglNKQSjssyKilYllGmS0iROmjoL_zJH74--w1j1oqmF9hY6PkyPsgduQPH_Ga1avjM_OGN5mhQsGLw-GVjzfRTO8165WnQdaGFGx2mZ0LQIeXPEjsLaGueskI8hlPCpaf7YNJ-a5oTxqekweP7vin_HTtUGwZujoFW7dq-s4K4PRQQ55fv9PmY8SXnBgvI3Lfu4lA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19314832</pqid></control><display><type>article</type><title>Phenotype of Striatofugal Medium Spiny Neurons in Parkinsonian and Dyskinetic Nonhuman Primates: A Call for a Reappraisal of the Functional Organization of the Basal Ganglia</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Nadjar, Agnes ; Brotchie, Jonathan M ; Guigoni, Celine ; Li, Qin ; Zhou, Shao-Bo ; Wang, Gui-Jie ; Ravenscroft, Paula ; Georges, Francois ; Crossman, Alan R ; Bezard, Erwan</creator><creatorcontrib>Nadjar, Agnes ; Brotchie, Jonathan M ; Guigoni, Celine ; Li, Qin ; Zhou, Shao-Bo ; Wang, Gui-Jie ; Ravenscroft, Paula ; Georges, Francois ; Crossman, Alan R ; Bezard, Erwan</creatorcontrib><description>The classic view of anatomofunctional organization of the basal ganglia is that striatopallidal neurons of the "indirect" pathway express D2 dopamine receptors and corelease enkephalin with GABA, whereas striatopallidal neurons of the "direct" pathway bear D1 dopamine receptors and corelease dynorphin and substance P with GABA. Although many studies have investigated the pathophysiology of the basal ganglia after dopamine denervation and subsequent chronic levodopa (L-dopa) treatment, none has ever considered the possibility of plastic changes leading to profound reorganization and/or biochemical phenotype modifications of medium spiny neurons. Therefore, we studied the phenotype of striatal neurons in four groups of nonhuman primates, including the following: normal, parkinsonian, parkinsonian chronically treated with L-dopa without exhibiting dyskinesia, and parkinsonian chronically treated with L-dopa exhibiting overt dyskinesia. To identify striatal cells projecting to external (indirect) or internal (direct) segments of the globus pallidus, the retrograde tracer cholera toxin subunit B (CTb) was injected stereotaxically into the terminal areas. Using immunohistochemistry techniques, brain sections were double labeled for CTb and dopamine receptors, opioid peptides, or the substance P receptor (NK1). We also used HPLC-RIA to assess opioid levels throughout structures of the basal ganglia. Our results suggest that medium spiny neurons retain their phenotype because no variations were observed in any experimental condition. Therefore, it appears unlikely that dyskinesia is related to a phenotype modification of the striatal neurons. However, this study supports the concept of axonal collateralization of striatofugal cells that project to both globus pallidus pars externa and globus pallidus pars interna. Striatofugal pathways are not as segregated in the primate as previously considered.</description><identifier>ISSN: 0270-6474</identifier><identifier>EISSN: 1529-2401</identifier><identifier>DOI: 10.1523/JNEUROSCI.2582-06.2006</identifier><identifier>PMID: 16928853</identifier><language>eng</language><publisher>United States: Soc Neuroscience</publisher><subject>Animals ; Basal Ganglia - physiopathology ; Cholera Toxin - administration &amp; dosage ; Cholera Toxin - pharmacokinetics ; Corpus Striatum - metabolism ; Corpus Striatum - pathology ; Corpus Striatum - physiopathology ; Dyskinesias - pathology ; Dyskinesias - physiopathology ; Female ; Globus Pallidus - metabolism ; Immunohistochemistry ; Injections ; Macaca fascicularis ; Macaca mulatta ; Neurons - metabolism ; Opioid Peptides - metabolism ; Parkinsonian Disorders - pathology ; Parkinsonian Disorders - physiopathology ; Phenotype ; Primates ; Receptors, Dopamine D1 - metabolism ; Receptors, Dopamine D2 - metabolism ; Receptors, Neurokinin-1 - metabolism ; Synaptic Transmission ; Tissue Distribution</subject><ispartof>The Journal of neuroscience, 2006-08, Vol.26 (34), p.8653-8661</ispartof><rights>Copyright © 2006 Society for Neuroscience 0270-6474/06/268653-09$15.00/0 2006</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c475t-b5a546bfb0e6fc1af5f1fbfef01b07883dfad9ee61f958b1b9a94341323dc5853</citedby><cites>FETCH-LOGICAL-c475t-b5a546bfb0e6fc1af5f1fbfef01b07883dfad9ee61f958b1b9a94341323dc5853</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6674386/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6674386/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16928853$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nadjar, Agnes</creatorcontrib><creatorcontrib>Brotchie, Jonathan M</creatorcontrib><creatorcontrib>Guigoni, Celine</creatorcontrib><creatorcontrib>Li, Qin</creatorcontrib><creatorcontrib>Zhou, Shao-Bo</creatorcontrib><creatorcontrib>Wang, Gui-Jie</creatorcontrib><creatorcontrib>Ravenscroft, Paula</creatorcontrib><creatorcontrib>Georges, Francois</creatorcontrib><creatorcontrib>Crossman, Alan R</creatorcontrib><creatorcontrib>Bezard, Erwan</creatorcontrib><title>Phenotype of Striatofugal Medium Spiny Neurons in Parkinsonian and Dyskinetic Nonhuman Primates: A Call for a Reappraisal of the Functional Organization of the Basal Ganglia</title><title>The Journal of neuroscience</title><addtitle>J Neurosci</addtitle><description>The classic view of anatomofunctional organization of the basal ganglia is that striatopallidal neurons of the "indirect" pathway express D2 dopamine receptors and corelease enkephalin with GABA, whereas striatopallidal neurons of the "direct" pathway bear D1 dopamine receptors and corelease dynorphin and substance P with GABA. Although many studies have investigated the pathophysiology of the basal ganglia after dopamine denervation and subsequent chronic levodopa (L-dopa) treatment, none has ever considered the possibility of plastic changes leading to profound reorganization and/or biochemical phenotype modifications of medium spiny neurons. Therefore, we studied the phenotype of striatal neurons in four groups of nonhuman primates, including the following: normal, parkinsonian, parkinsonian chronically treated with L-dopa without exhibiting dyskinesia, and parkinsonian chronically treated with L-dopa exhibiting overt dyskinesia. To identify striatal cells projecting to external (indirect) or internal (direct) segments of the globus pallidus, the retrograde tracer cholera toxin subunit B (CTb) was injected stereotaxically into the terminal areas. Using immunohistochemistry techniques, brain sections were double labeled for CTb and dopamine receptors, opioid peptides, or the substance P receptor (NK1). We also used HPLC-RIA to assess opioid levels throughout structures of the basal ganglia. Our results suggest that medium spiny neurons retain their phenotype because no variations were observed in any experimental condition. Therefore, it appears unlikely that dyskinesia is related to a phenotype modification of the striatal neurons. However, this study supports the concept of axonal collateralization of striatofugal cells that project to both globus pallidus pars externa and globus pallidus pars interna. Striatofugal pathways are not as segregated in the primate as previously considered.</description><subject>Animals</subject><subject>Basal Ganglia - physiopathology</subject><subject>Cholera Toxin - administration &amp; dosage</subject><subject>Cholera Toxin - pharmacokinetics</subject><subject>Corpus Striatum - metabolism</subject><subject>Corpus Striatum - pathology</subject><subject>Corpus Striatum - physiopathology</subject><subject>Dyskinesias - pathology</subject><subject>Dyskinesias - physiopathology</subject><subject>Female</subject><subject>Globus Pallidus - metabolism</subject><subject>Immunohistochemistry</subject><subject>Injections</subject><subject>Macaca fascicularis</subject><subject>Macaca mulatta</subject><subject>Neurons - metabolism</subject><subject>Opioid Peptides - metabolism</subject><subject>Parkinsonian Disorders - pathology</subject><subject>Parkinsonian Disorders - physiopathology</subject><subject>Phenotype</subject><subject>Primates</subject><subject>Receptors, Dopamine D1 - metabolism</subject><subject>Receptors, Dopamine D2 - metabolism</subject><subject>Receptors, Neurokinin-1 - metabolism</subject><subject>Synaptic Transmission</subject><subject>Tissue Distribution</subject><issn>0270-6474</issn><issn>1529-2401</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVUd1u0zAYtRCIlcIrTL6CqxQ7P07CBdJWtjE02mpl19aXxG4MiR1sh6q8E--Io5YBV5bPOd85n30QOqdkQbM4eftpdfVwv94ubxdxVsQRYYuYEPYEzQJbRnFK6FM0I3FOIpbm6Rl64dxXQkhOaP4cnVFWxkWRJTP0a9MKbfxhENhIvPVWgTdy3EGHP4tGjT3eDkof8EqM1miHlcYbsN-UdkYr0Bh0gz8cXACEVzVeGd2OfcA3VvXghXuHL_ASug5LYzHgewHDYEG54B_yfCvw9ahrr4wOyNruQKufMF3_0JcwaW9A7zoFL9EzCZ0Tr07nHD1cX31Zfozu1je3y4u7qE7zzEdVBlnKKlkRwWRNQWaSykoKSWhF8qJIGglNKQSjssyKilYllGmS0iROmjoL_zJH74--w1j1oqmF9hY6PkyPsgduQPH_Ga1avjM_OGN5mhQsGLw-GVjzfRTO8165WnQdaGFGx2mZ0LQIeXPEjsLaGueskI8hlPCpaf7YNJ-a5oTxqekweP7vin_HTtUGwZujoFW7dq-s4K4PRQQ55fv9PmY8SXnBgvI3Lfu4lA</recordid><startdate>20060823</startdate><enddate>20060823</enddate><creator>Nadjar, Agnes</creator><creator>Brotchie, Jonathan M</creator><creator>Guigoni, Celine</creator><creator>Li, Qin</creator><creator>Zhou, Shao-Bo</creator><creator>Wang, Gui-Jie</creator><creator>Ravenscroft, Paula</creator><creator>Georges, Francois</creator><creator>Crossman, Alan R</creator><creator>Bezard, Erwan</creator><general>Soc Neuroscience</general><general>Society for Neuroscience</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7TK</scope><scope>C1K</scope><scope>5PM</scope></search><sort><creationdate>20060823</creationdate><title>Phenotype of Striatofugal Medium Spiny Neurons in Parkinsonian and Dyskinetic Nonhuman Primates: A Call for a Reappraisal of the Functional Organization of the Basal Ganglia</title><author>Nadjar, Agnes ; Brotchie, Jonathan M ; Guigoni, Celine ; Li, Qin ; Zhou, Shao-Bo ; Wang, Gui-Jie ; Ravenscroft, Paula ; Georges, Francois ; Crossman, Alan R ; Bezard, Erwan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c475t-b5a546bfb0e6fc1af5f1fbfef01b07883dfad9ee61f958b1b9a94341323dc5853</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Animals</topic><topic>Basal Ganglia - physiopathology</topic><topic>Cholera Toxin - administration &amp; dosage</topic><topic>Cholera Toxin - pharmacokinetics</topic><topic>Corpus Striatum - metabolism</topic><topic>Corpus Striatum - pathology</topic><topic>Corpus Striatum - physiopathology</topic><topic>Dyskinesias - pathology</topic><topic>Dyskinesias - physiopathology</topic><topic>Female</topic><topic>Globus Pallidus - metabolism</topic><topic>Immunohistochemistry</topic><topic>Injections</topic><topic>Macaca fascicularis</topic><topic>Macaca mulatta</topic><topic>Neurons - metabolism</topic><topic>Opioid Peptides - metabolism</topic><topic>Parkinsonian Disorders - pathology</topic><topic>Parkinsonian Disorders - physiopathology</topic><topic>Phenotype</topic><topic>Primates</topic><topic>Receptors, Dopamine D1 - metabolism</topic><topic>Receptors, Dopamine D2 - metabolism</topic><topic>Receptors, Neurokinin-1 - metabolism</topic><topic>Synaptic Transmission</topic><topic>Tissue Distribution</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nadjar, Agnes</creatorcontrib><creatorcontrib>Brotchie, Jonathan M</creatorcontrib><creatorcontrib>Guigoni, Celine</creatorcontrib><creatorcontrib>Li, Qin</creatorcontrib><creatorcontrib>Zhou, Shao-Bo</creatorcontrib><creatorcontrib>Wang, Gui-Jie</creatorcontrib><creatorcontrib>Ravenscroft, Paula</creatorcontrib><creatorcontrib>Georges, Francois</creatorcontrib><creatorcontrib>Crossman, Alan R</creatorcontrib><creatorcontrib>Bezard, Erwan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Neurosciences Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Journal of neuroscience</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nadjar, Agnes</au><au>Brotchie, Jonathan M</au><au>Guigoni, Celine</au><au>Li, Qin</au><au>Zhou, Shao-Bo</au><au>Wang, Gui-Jie</au><au>Ravenscroft, Paula</au><au>Georges, Francois</au><au>Crossman, Alan R</au><au>Bezard, Erwan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Phenotype of Striatofugal Medium Spiny Neurons in Parkinsonian and Dyskinetic Nonhuman Primates: A Call for a Reappraisal of the Functional Organization of the Basal Ganglia</atitle><jtitle>The Journal of neuroscience</jtitle><addtitle>J Neurosci</addtitle><date>2006-08-23</date><risdate>2006</risdate><volume>26</volume><issue>34</issue><spage>8653</spage><epage>8661</epage><pages>8653-8661</pages><issn>0270-6474</issn><eissn>1529-2401</eissn><abstract>The classic view of anatomofunctional organization of the basal ganglia is that striatopallidal neurons of the "indirect" pathway express D2 dopamine receptors and corelease enkephalin with GABA, whereas striatopallidal neurons of the "direct" pathway bear D1 dopamine receptors and corelease dynorphin and substance P with GABA. Although many studies have investigated the pathophysiology of the basal ganglia after dopamine denervation and subsequent chronic levodopa (L-dopa) treatment, none has ever considered the possibility of plastic changes leading to profound reorganization and/or biochemical phenotype modifications of medium spiny neurons. Therefore, we studied the phenotype of striatal neurons in four groups of nonhuman primates, including the following: normal, parkinsonian, parkinsonian chronically treated with L-dopa without exhibiting dyskinesia, and parkinsonian chronically treated with L-dopa exhibiting overt dyskinesia. To identify striatal cells projecting to external (indirect) or internal (direct) segments of the globus pallidus, the retrograde tracer cholera toxin subunit B (CTb) was injected stereotaxically into the terminal areas. Using immunohistochemistry techniques, brain sections were double labeled for CTb and dopamine receptors, opioid peptides, or the substance P receptor (NK1). We also used HPLC-RIA to assess opioid levels throughout structures of the basal ganglia. Our results suggest that medium spiny neurons retain their phenotype because no variations were observed in any experimental condition. Therefore, it appears unlikely that dyskinesia is related to a phenotype modification of the striatal neurons. However, this study supports the concept of axonal collateralization of striatofugal cells that project to both globus pallidus pars externa and globus pallidus pars interna. Striatofugal pathways are not as segregated in the primate as previously considered.</abstract><cop>United States</cop><pub>Soc Neuroscience</pub><pmid>16928853</pmid><doi>10.1523/JNEUROSCI.2582-06.2006</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0270-6474
ispartof The Journal of neuroscience, 2006-08, Vol.26 (34), p.8653-8661
issn 0270-6474
1529-2401
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6674386
source MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Animals
Basal Ganglia - physiopathology
Cholera Toxin - administration & dosage
Cholera Toxin - pharmacokinetics
Corpus Striatum - metabolism
Corpus Striatum - pathology
Corpus Striatum - physiopathology
Dyskinesias - pathology
Dyskinesias - physiopathology
Female
Globus Pallidus - metabolism
Immunohistochemistry
Injections
Macaca fascicularis
Macaca mulatta
Neurons - metabolism
Opioid Peptides - metabolism
Parkinsonian Disorders - pathology
Parkinsonian Disorders - physiopathology
Phenotype
Primates
Receptors, Dopamine D1 - metabolism
Receptors, Dopamine D2 - metabolism
Receptors, Neurokinin-1 - metabolism
Synaptic Transmission
Tissue Distribution
title Phenotype of Striatofugal Medium Spiny Neurons in Parkinsonian and Dyskinetic Nonhuman Primates: A Call for a Reappraisal of the Functional Organization of the Basal Ganglia
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T15%3A22%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Phenotype%20of%20Striatofugal%20Medium%20Spiny%20Neurons%20in%20Parkinsonian%20and%20Dyskinetic%20Nonhuman%20Primates:%20A%20Call%20for%20a%20Reappraisal%20of%20the%20Functional%20Organization%20of%20the%20Basal%20Ganglia&rft.jtitle=The%20Journal%20of%20neuroscience&rft.au=Nadjar,%20Agnes&rft.date=2006-08-23&rft.volume=26&rft.issue=34&rft.spage=8653&rft.epage=8661&rft.pages=8653-8661&rft.issn=0270-6474&rft.eissn=1529-2401&rft_id=info:doi/10.1523/JNEUROSCI.2582-06.2006&rft_dat=%3Cproquest_pubme%3E19314832%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=19314832&rft_id=info:pmid/16928853&rfr_iscdi=true